Increased levels of sphingosylphosphorylcholine (spc) in plasma of metabolic syndrome patients

HIGHLIGHTS

• who: Nahed El-Najjar and collaborators from the Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany have published the research: Increased Levels of Sphingosylphosphorylcholine (SPC) in Plasma of Metabolic Syndrome Patients, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0140683]. October 14, 2015 of August/18,/2015
• what: The authors analyzed plasma lipid species in patients at risk for diabesity and the metabolic syndrome and compared them with healthy controls. Collectively the study provides new information on SPC plasma levels in metabolic syndrome and suggests new avenues for investigation . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.